Ambit BioScience Is Up Almost 70 Percent Since Its Offering

by Elizabeth Krutoholow

Ambit Biosciences, which set its IPO at $8 for 8.125 million shares in May, is up almost 70 percent since its market debut. The stock dropped 25 percent in the past month after third quarter earnings were announced on Nov. 6 and ahead of a lockup expiration on Nov. 11.


Read more >>>


Bloomberg BRIEF Newsletters